Isis Cholesterol Drug Submitted in Europe

A cholesterol-lowering drug discovered and developed by Isis Pharmaceuticals has been submitted for market approval in Europe by the Carlsbad company’s partner, Genzyme, the drug developers said.
Sigon San Diego